FDA Clears First Nebulized LAMA Inhaler for COPD

Share this post

Glycopyrrolate inhalation solution 25 mcg twice daily (Lonhala Magnair) is for maintenance treatment of airflow obstruction in adults with chronic obstructive pulmonary disease (COPD).
FDA Approvals

This post was syndicated from Medscape Medical News Headlines. Click here to read the full text on the original website.

Share this post

Be the first to comment

Leave a Reply